| Metric | FY 2026↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.6B | $9.1B | $11.3B | $11.2B | $11.0B | $2.4B | $2.1B | $2.1B |
| Cost of Revenue | $4.9B | $5.7B | $6.8B | $6.2B | $6.1B | $5.6B | $5.5B | $5.4B |
| Gross Profit | $3.7B | $3.4B | $4.5B | $5.0B | $4.9B | $1.1B | $0.9B | $0.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.6B | $3.8B | $4.4B | $4.2B | $4.1B | $3.7B | $3.6B | $3.6B |
| Operating Income | $-0.0B | $-0.7B | $0.1B | $0.7B | $0.8B | $0.7B | $0.7B | $0.6B |
| Net Income | $0.0B | $-0.3B | $0.0B | $0.5B | $0.6B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $0.73 | $-5.63 | $0.50 | $8.32 | $9.62 | $1.66 | $1.39 | $0.74 |
| EPS (Diluted) | $0.73 | $-5.61 | $0.50 | $8.27 | $9.55 | $1.65 | $1.38 | $0.74 |
| Metric | FY 2026↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.8B | $10.8B | $12.3B | $12.0B | $12.2B | $11.8B | $11.2B | $9.0B |
| Current Assets | $7.3B | $6.1B | $6.4B | $6.0B | $6.3B | $6.3B | $5.7B | $6.1B |
| Cash & Equivalents | $3.1B | $1.9B | $0.5B | $0.3B | $0.6B | $0.8B | $0.4B | $0.9B |
| Total Liabilities | $9.6B | $8.6B | $9.8B | $9.3B | $9.1B | — | — | — |
| Current Liabilities | $4.2B | $4.7B | $5.3B | $5.4B | $5.2B | $4.7B | $4.5B | $3.9B |
| Stockholders' Equity | $2.2B | $2.2B | $2.5B | $2.7B | $3.1B | $3.6B | $3.5B | $3.6B |
| Metric | FY 2026↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.0B | $0.1B | $0.3B | $0.7B | $1.1B | $1.0B | $0.9B | $0.8B |
| Investing Cash Flow | $-0.2B | $1.4B | $-0.2B | $-0.4B | $-0.3B | $-0.3B | $-0.5B | $-0.2B |
| Capital Expenditures | $0.3B | $0.2B | $0.2B | $0.4B | $0.3B | $0.3B | $0.3B | $0.2B |
| Financing Cash Flow | $1.5B | $-0.1B | $0.2B | $-0.6B | $-1.1B | $-0.3B | $-0.9B | $-0.3B |